ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1026

Molecular Mechanism of High-Potassium Induced Na-Cl Cotransporter Dephosphorylation

Session Information

Category: Fluid and Electrolytes

  • 901 Fluid and Electrolytes: Basic

Authors

  • Shoda, Wakana, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Nomura, Naohiro, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Ando, Fumiaki, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Isobe, Kiyoshi, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Mori, Takayasu, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Sohara, Eisei, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Rai, Tatemitsu, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan
  • Uchida, Shinichi, Tokyo Medical and Dental University, Tokyo, TOKYO, Japan

Group or Team Name

  • Tokyo Medical and Dental University Department of Nephrology
Background

Sodium-chloride cotransporter (NCC), expressed in distal convoluted tubules (DCT), is a key molecule in the regulation of urinary potassium (K+) excretion. We previously reported that tacrolimus (a calcineurin inhibitor) and W7 (a calmodulin inhibitor) inhibited the K+-induced NCC dephosphorylation and the increase in urinary K+ excretion in mouse kidneys. These results suggest that calmodulin and calcineurin (CaN) were activated by calcium (Ca2+) signal in response to the increase in extracellular K+ concentration ([K+]ex) in DCT. However, the precise mechanism of K+-induced CaN activation in DCT cells remains unknown.

Methods

Flp-in NCC HEK293 cells were transfected with constitutively active CaN-A (CA-CaN-A), CaN-A, and -B plasmids to determine the role of CaN in NCC dephosphorylation. Intracellular Ca2+ concentration ([Ca2+]i) were analyzed by live cell imaging using fluo-4 AM. SEA0400 (an NCX reverse-mode inhibitor) and ω-agatoxin (a P/Q type Ca2+ channel inhibitor) were injected to C57BL/6 mice 1 hour before K+ oral gavage.

Results

We confirmed that CA-CaN-A over-expression clearly dephosphorylated NCC in HEK293 cells. In the following experiments, we used HEK293 cells in which both CaN-A and CaN-B were transiently overexpressed. In these cells, K+-induced NCC dephosphorylation was inhibited by tacrolimus and EGTA treatment. The rapid increase in [Ca2+]i after high K+ stimulation was not observed with EGTA treatment, suggesting that the increase in [Ca2+]i after K+ stimulation was caused by Ca2+ influx. To determine the influx pathway, we treated the cells with several Ca2+ transporter inhibitors, and identified that SEA0400 and ω-agatoxin inhibited the K+-induced [Ca2+]i increase and NCC dephosphorylation. Furthermore, we found that both SEA0400 and ω-agatoxin inhibited K+-induced NCC dephosphorylation in mouse kidneys.

Conclusion

This study showed that the K+-induced NCC dephosphorylation by CaN was mediated by high-[K+]ex-induced influx of Ca2+ through reverse-mode NCX and/or P/Q type Ca2+ channel.